<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: transmission of hiv</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>A shortcut to timely, cost-effective interventions for HIV</title>
   	 <description>South Africa is home to the largest HIV epidemic in the world with a total of 5.6 million people living with HIV. Large-scale clinical trials evaluating combination methods of prevention and treatment are often prohibitively expensive and take years to complete. In the absence of such trials, mathematical models can help assess the effectiveness of different HIV intervention combinations, as demonstrated in a new study by Elisa Long and Robert Stavert from Yale University in the US. Their findings appear in the Journal of General Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2013-04-shortcut-cost-effective-interventions-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 15 Apr 2013 11:40:01 EST</pubDate>
	 <guid isPermaLink="false">news285243996</guid>
	 
</item>
<item>
     <title>Gel safe and acceptable as approach to preventing HIV from anal sex</title>
   	 <description>A reformulated version of an anti-HIV gel developed for vaginal use was found safe and acceptable by HIV-negative men and women who used it rectally, according to a Phase I clinical trial published today in PLOS ONE. The study, led by researchers with the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), tested a reduced glycerin formulation of tenofovir gel, and has spurred the development of an expanded safety study of the gel, expected to launch later this year.</description>
     <link>http://medicalxpress.com/news/2013-04-gel-safe-approach-hiv-anal.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 03 Apr 2013 17:00:11 EST</pubDate>
	 <guid isPermaLink="false">news284215947</guid>
	 
</item>
<item>
     <title>Innate immune system can kill HIV when a viral gene is deactivated</title>
   	 <description>Human cells have an intrinsic capacity to destroy HIV. However, the virus has evolved to contain a gene that blocks this ability. When this gene is removed from the virus, the innate human immune system destroys HIV by mutating it to the point where it can no longer survive.</description>
     <link>http://medicalxpress.com/news/2013-03-innate-immune-hiv-viral-gene.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 28 Mar 2013 17:00:03 EST</pubDate>
	 <guid isPermaLink="false">news283707538</guid>
	 
</item>
<item>
     <title>New research calls for better guidance about HIV transmission and the law</title>
   	 <description>Support services for people living with HIV will benefit from better information about prosecutions for the sexual transmission of HIV, according to a report released today by researchers from Sigma Research at the London School of Hygiene &amp; Tropical Medicine, and Birkbeck, University of London.</description>
     <link>http://medicalxpress.com/news/2013-03-guidance-hiv-transmission-law.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 05 Mar 2013 19:00:04 EST</pubDate>
	 <guid isPermaLink="false">news281723817</guid>
	 
</item>
<item>
     <title>Vaginal microbicide gel may offer a promising strategy for prevention and protection against HIV transmission</title>
   	 <description>A new study shows that a microbicide gel is highly effective in block infection by the AIDS virus in a non-human primate model. In the paper published December 6 in the Open Access journal PLOS Pathogens, Dereuddre-Bosquet and colleagues from the European Combined Highly Active Anti-Retroviral Microbicides (CHAARM) Consortium describe the gel's key ingredient, which are small peptides engineered to present a decoy to bind up the virus and prevent it from entering and infecting the cells of the body. Because this is a gel it can be topically applied and could represent a powerful preventative agent against sexual transmission of HIV.</description>
     <link>http://medicalxpress.com/news/2012-12-vaginal-microbicide-gel-strategy-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 06 Dec 2012 17:10:02 EST</pubDate>
	 <guid isPermaLink="false">news274031729</guid>
	 
</item>
<item>
     <title>HIV and AIDS prevention—Progress and the challenges ahead</title>
   	 <description>At least 2 million people worldwide will be infected with HIV this year, driving the need for better HIV prevention strategies to slow the global pandemic. A better understanding of how to prevent HIV transmission using antiviral drugs led to approval of the first oral pill for HIV prevention, and microbicides delivered as topical gels or via intravaginal rings are in clinical testing and have yielded both positive and negative results. The complex factors involved in the sexual transmission of HIV, the urgent need for new preventive approaches, and the most promising methods currently in development are examined in a special issue of AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc, publishers.</description>
     <link>http://medicalxpress.com/news/2012-11-hiv-aids-preventionprogress.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 05 Nov 2012 16:37:39 EST</pubDate>
	 <guid isPermaLink="false">news271355847</guid>
	 
</item>
<item>
     <title>Methadone reduces risk of HIV transmission in people who inject drugs, say experts</title>
   	 <description>(Medical Xpress)—People who inject drugs (PWID) can significantly reduce their risk of HIV infection with the use of opiate substitution treatments such as methadone, as suggested by an international team of researchers in a paper published today on bmj.com.</description>
     <link>http://medicalxpress.com/news/2012-10-methadone-hiv-transmission-people-drugs.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 05 Oct 2012 09:26:19 EST</pubDate>
	 <guid isPermaLink="false">news268647951</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-image(9).jpg" width="90" height="90" />
</item>
<item>
     <title>Starting antiretroviral therapy improves HIV-infected Africans' nutrition</title>
   	 <description>Starting HIV-infected patients on antiretroviral therapy reduces food insecurity and improves physical health, thereby contributing to the disruption of a lethal syndemic, UCSF and Massachusetts General Hospital researchers have found in a study focused on sub-Saharan Africa.</description>
     <link>http://medicalxpress.com/news/2012-10-antiretroviral-therapy-hiv-infected-africans-nutrition.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 02 Oct 2012 14:15:59 EST</pubDate>
	 <guid isPermaLink="false">news268406147</guid>
	 
</item>
<item>
     <title>HIV home testing kits prove their worth</title>
   	 <description>Thirty years into the HIV epidemic, many people who are at high risk of HIV infection cannot or will not adopt safer sexual practices, such as abstinence and condom use. This means there is room in the market for alternative methods to reduce either exposure to or transmission of HIV among these individuals. One such strategy, HIV home testing (HT), is the subject of a recent study by Alex Carballo-Dieguez and his colleagues at the HIV Center for Clinical and Behavioral Studies at New York. Their work appears online in the journal AIDS and Behavior.</description>
     <link>http://medicalxpress.com/news/2012-08-hiv-home-kits-worth.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 20 Aug 2012 12:56:21 EST</pubDate>
	 <guid isPermaLink="false">news264686109</guid>
	 
</item>
<item>
     <title>Two-thirds of U.S. youth have had oral sex, CDC reports</title>
   	 <description>(HealthDay) -- Two-thirds of Americans aged 15 to 24 have engaged in oral sex, according to a broad new survey of young people's sexual habits.</description>
     <link>http://medicalxpress.com/news/2012-08-two-thirds-youth-oral-sex-cdc.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 16 Aug 2012 11:20:01 EST</pubDate>
	 <guid isPermaLink="false">news264332826</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/twothirdsofu.jpg" width="90" height="90" />
</item>
<item>
     <title>Study finds non-disclosure of HIV serostatus common among India female sex workers</title>
   	 <description>Researchers from Boston University School of Medicine (BUSM) in partnership with Indian researchers and HIV positive networks groups, have found that in India, non-disclosure of HIV serostatus to sex partners among both HIV-infected female sex workers (FSWs) and HIV-infected clients of FSWs is exceedingly common. These findings currently appear online in the journal AIDS and Behavior.</description>
     <link>http://medicalxpress.com/news/2012-07-non-disclosure-hiv-serostatus-common-india.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 23 Jul 2012 12:43:25 EST</pubDate>
	 <guid isPermaLink="false">news262266143</guid>
	 
</item>
<item>
     <title>UNAIDS welcomes US approval of drug to stop HIV</title>
   	 <description> The UN agency tasked with fighting AIDS on Tuesday welcomed the decision by the United States to allow the use of an HIV prevention pill for the first time.</description>
     <link>http://medicalxpress.com/news/2012-07-unaids-drug-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 17 Jul 2012 06:38:40 EST</pubDate>
	 <guid isPermaLink="false">news261725914</guid>
	 
</item>
<item>
     <title>Bacterial vaginosis is associated with higher risk of female-to-male transmission of HIV</title>
   	 <description>An investigation led by UCSF has found that the risk of female-to-male HIV transmission is increased three fold for women with bacterial vaginosis, a common disorder in which the normal balance of bacteria in the vagina is disrupted.</description>
     <link>http://medicalxpress.com/news/2012-06-bacterial-vaginosis-higher-female-to-male-transmission.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 26 Jun 2012 17:00:07 EST</pubDate>
	 <guid isPermaLink="false">news259944658</guid>
	 
</item>
<item>
     <title>Drug combo much better than AZT alone at preventing mother-to-infant HIV transmission</title>
   	 <description>Non-breastfed babies born to HIV-positive mothers who didn't receive antiretroviral therapy during pregnancy are routinely given zidovudine, commonly known as AZT, shortly after birth to prevent mother-to-child transmission of the virus that causes AIDS.</description>
     <link>http://medicalxpress.com/news/2012-06-drug-combo-azt-mother-to-infant-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 20 Jun 2012 17:00:08 EST</pubDate>
	 <guid isPermaLink="false">news259417234</guid>
	 
</item>
<item>
     <title>Breast milk kills HIV and blocks its oral transmission in humanized mouse</title>
   	 <description>More than 15 percent of new HIV infections occur in children. Without treatment, only 65 percent of HIV-infected children will live until their first birthday, and fewer than half will make it to the age of two. Although breastfeeding is attributed to a significant number of these infections, most breastfed infants are not infected with HIV, despite prolonged and repeated exposure.</description>
     <link>http://medicalxpress.com/news/2012-06-breast-hiv-blocks-oral-transmission.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 14 Jun 2012 16:59:30 EST</pubDate>
	 <guid isPermaLink="false">news258911954</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/breastmilkki.jpg" width="90" height="90" />
</item>
<item>
     <title>Will women use microbicides to protect themselves against HIV?</title>
   	 <description>Are women willing to use a vaginal gel to protect themselves against HIV infection? Researchers at The Miriam Hospital say that is the million dollar question when it comes to developing products known as microbicides that can prevent the sexual transmission of HIV.</description>
     <link>http://medicalxpress.com/news/2012-04-women-microbicides-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 19 Apr 2012 13:20:02 EST</pubDate>
	 <guid isPermaLink="false">news254058949</guid>
	 
</item>
<item>
     <title>Rectal formulation of tenofovir gel safe and acceptable in early phase clinical study</title>
   	 <description>A gel formulation of the antiretroviral drug tenofovir designed specifically for rectal use was found safe and acceptable, according to a Phase I clinical study led by the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), and presented today at the 19th Conference on Retroviruses and Opportunistic Infections (CROI). The results of the study, which included HIV-negative men and women who used the gel rectally once a day for one week, serve as an important step toward the development and testing of a rectal microbicide to prevent HIV from anal sex.</description>
     <link>http://medicalxpress.com/news/2012-03-rectal-tenofovir-gel-safe-early.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 06 Mar 2012 04:20:01 EST</pubDate>
	 <guid isPermaLink="false">news250228749</guid>
	 
</item>
<item>
     <title>Business, social media to prevent babies with HIV</title>
   	 <description>(AP) --  Business and social media leaders teamed up Friday to tackle the transmission of HIV from mothers to babies, saying the medicine and the money are largely in place, and with the right organizational skills they can eliminate HIV-infected births by 2015.</description>
     <link>http://medicalxpress.com/news/2012-01-business-social-media-babies-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 27 Jan 2012 06:40:01 EST</pubDate>
	 <guid isPermaLink="false">news246867458</guid>
	 
</item>
<item>
     <title>HIV prevention research named scientific breakthrough of the year by Science</title>
   	 <description>The HIV Prevention Trials Network 052 study, led by Myron S. Cohen, MD of the University of North Carolina at Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science.</description>
     <link>http://medicalxpress.com/news/2011-12-hiv-scientific-breakthrough-year-science.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 22 Dec 2011 14:00:09 EST</pubDate>
	 <guid isPermaLink="false">news243779772</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/hivpreventio.jpg" width="90" height="90" />
</item>
<item>
     <title>Abolish the criminalization of HIV</title>
   	 <description>Routine criminal prosecutions for not disclosing HIV status should be abolished, write three HIV/AIDS experts in an article in CMAJ (Canadian Medical Association Journal).</description>
     <link>http://medicalxpress.com/news/2011-12-abolish-criminalization-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 19 Dec 2011 12:00:07 EST</pubDate>
	 <guid isPermaLink="false">news243517029</guid>
	 
</item>
<item>
     <title>HIV spreading in Europe, but AIDS cases declining: study</title>
   	 <description> HIV infections continued to rise in Europe in 2010, but thanks to treatment the number of cases of full-blown AIDS has dramatically declined in recent years, according to a report published Wednesday.  </description>
     <link>http://medicalxpress.com/news/2011-11-hiv-europe-aids-cases-declining.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 30 Nov 2011 08:11:45 EST</pubDate>
	 <guid isPermaLink="false">news241863094</guid>
	 
</item>
<item>
     <title>HIV trial scrapped after gel found to be ineffective</title>
   	 <description> In a major setback for AIDS prevention research, a clinical trial of a new vaginal gel supposed to reduce HIV infections has been suspended after studies showed it to be ineffective.</description>
     <link>http://medicalxpress.com/news/2011-11-hiv-trial-scrapped-gel-ineffective.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Sun, 27 Nov 2011 12:50:01 EST</pubDate>
	 <guid isPermaLink="false">news241619690</guid>
	 
</item>
<item>
     <title>Could engineered fatty particles help prevent AIDS?</title>
   	 <description>Could engineered fatty particles help prevent AIDS? Liposomes block HIV infection in early tests; could be a cost-effective preventive for developing countries</description>
     <link>http://medicalxpress.com/news/2011-09-fatty-particles-aids.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 19 Sep 2011 16:48:44 EST</pubDate>
	 <guid isPermaLink="false">news235669669</guid>
	 
</item>
<item>
     <title>First large study to find HIV epidemic among gays in the Middle East</title>
   	 <description>HIV epidemics are emerging in several countries in the Middle East and North Africa among men who have sex with men, a term that encompasses gay, non-gay identified homosexual men, and transgendered and bisexual men.</description>
     <link>http://medicalxpress.com/news/2011-08-large-hiv-epidemic-gays-middle.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 03 Aug 2011 03:40:03 EST</pubDate>
	 <guid isPermaLink="false">news231560040</guid>
	 
</item>
<item>
     <title>Clinical tests for medicines made from genetically modified plants</title>
   	 <description>UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.</description>
     <link>http://medicalxpress.com/news/2011-07-clinical-medicines-genetically.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 21 Jul 2011 10:29:35 EST</pubDate>
	 <guid isPermaLink="false">news230462955</guid>
	 
</item>
<item>
     <title>Stopping HIV transmission with a molecular barrier</title>
   	 <description>Using a technique that silences genes promoting infection, researchers have developed a novel, topically-applied molecular microbicide capable of preventing HIV transmission. The microbicide is predicted to have long-lasting effects in mice, opening the door to developing an intravaginal microbicide that could protect women against HIV infection potentially for weeks at a time and bolster public health efforts to halt the spread of HIV/AIDS.</description>
     <link>http://medicalxpress.com/news/2011-05-aptamer-approach-hiv-transmission.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 16 May 2011 12:38:44 EST</pubDate>
	 <guid isPermaLink="false">news224768311</guid>
	 
</item>
<item>
     <title>Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners</title>
   	 <description>Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners by taking oral antiretroviral medicines when their immune systems were relatively healthy, according to findings from a large-scale clinical study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.</description>
     <link>http://medicalxpress.com/news/2011-05-hiv-infected-people-antiretrovirals-significantly-transmission.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 12 May 2011 11:43:02 EST</pubDate>
	 <guid isPermaLink="false">news224419358</guid>
	 
</item>


</channel>
</rss>
